Clinical impact of hematogones on outcomes of allogeneic hematopoietic stem cell transplantation View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2015-09-04

AUTHORS

Noriko Doki, Kyoko Haraguchi, Takeshi Hagino, Aiko Igarashi, Yuho Najima, Takeshi Kobayashi, Kazuhiko Kakihana, Yoshiki Okuyama, Hisashi Sakamaki, Kazuteru Ohashi

ABSTRACT

Increased levels of normal B cell precursors, termed hematogones (HGs), are observed in regenerating bone marrow after chemotherapy or hematopoietic stem cell transplantation (HSCT). Recent reports suggest that emergence of HGs is associated with better outcomes following allogeneic HSCT (allo-HSCT). We reviewed the emergence of HGs and the clinical features of 192 patients after allo-BMT. Patients undergoing allo-BMT from related donors were more likely to develop HGs at day 30 compared to unrelated donors. Furthermore, patients undergoing allo-BMT from HLA-mismatched donors were less likely to develop HGs at day 30. The emergence of HGs at day 30 was an independent prognostic factor among patients who underwent BMT. We found no difference in the relapse rate between HG-positive (+) and HG-negative (−) patients undergoing BMT. HG (−) patients had high non-relapse mortality, grade II to IV acute graft-versus-host-disease (GVHD), fungal infection, and lower IgG levels compared to HG (+) patients. The emergence of HGs at day 30 among patients undergoing BMT may be a very useful indicator of subsequent survival outcomes or acute GVHD in common clinical practice. More... »

PAGES

2055-2060

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00277-015-2492-y

DOI

http://dx.doi.org/10.1007/s00277-015-2492-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1045268198

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26336968


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Allografts", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Marrow", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematologic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Histocompatibility Testing", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Count", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Precursor Cells, B-Lymphoid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Regeneration", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415479.a", 
          "name": [
            "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Doki", 
        "givenName": "Noriko", 
        "id": "sg:person.01240752436.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240752436.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415479.a", 
          "name": [
            "Division of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haraguchi", 
        "givenName": "Kyoko", 
        "id": "sg:person.0644344774.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644344774.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415479.a", 
          "name": [
            "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hagino", 
        "givenName": "Takeshi", 
        "id": "sg:person.01142075071.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142075071.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415479.a", 
          "name": [
            "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Igarashi", 
        "givenName": "Aiko", 
        "id": "sg:person.0643633551.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643633551.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415479.a", 
          "name": [
            "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Najima", 
        "givenName": "Yuho", 
        "id": "sg:person.01214267464.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01214267464.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415479.a", 
          "name": [
            "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kobayashi", 
        "givenName": "Takeshi", 
        "id": "sg:person.01355201036.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355201036.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415479.a", 
          "name": [
            "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kakihana", 
        "givenName": "Kazuhiko", 
        "id": "sg:person.0677710136.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677710136.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415479.a", 
          "name": [
            "Division of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Okuyama", 
        "givenName": "Yoshiki", 
        "id": "sg:person.01243551065.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243551065.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415479.a", 
          "name": [
            "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sakamaki", 
        "givenName": "Hisashi", 
        "id": "sg:person.01143751601.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143751601.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415479.a", 
          "name": [
            "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ohashi", 
        "givenName": "Kazuteru", 
        "id": "sg:person.012430503152.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012430503152.76"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/bmt.2013.34", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001540761", 
          "https://doi.org/10.1038/bmt.2013.34"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2401279", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018364937", 
          "https://doi.org/10.1038/sj.leu.2401279"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2011.93", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011498187", 
          "https://doi.org/10.1038/bmt.2011.93"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-09-04", 
    "datePublishedReg": "2015-09-04", 
    "description": "Increased levels of normal B cell precursors, termed hematogones (HGs), are observed in regenerating bone marrow after chemotherapy or hematopoietic stem cell transplantation (HSCT). Recent reports suggest that emergence of HGs is associated with better outcomes following allogeneic HSCT (allo-HSCT). We reviewed the emergence of HGs and the clinical features of 192 patients after allo-BMT. Patients undergoing allo-BMT from related donors were more likely to develop HGs at day 30 compared to unrelated donors. Furthermore, patients undergoing allo-BMT from HLA-mismatched donors were less likely to develop HGs at day 30. The emergence of HGs at day 30 was an independent prognostic factor among patients who underwent BMT. We found no difference in the relapse rate between HG-positive (+) and HG-negative (\u2212) patients undergoing BMT. HG (\u2212) patients had high non-relapse mortality, grade II to IV acute graft-versus-host-disease (GVHD), fungal infection, and lower IgG levels compared to HG (+) patients. The emergence of HGs at day 30 among patients undergoing BMT may be a very useful indicator of subsequent survival outcomes or acute GVHD in common clinical practice.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00277-015-2492-y", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1358129", 
        "issn": [
          "0939-5555", 
          "1432-0584"
        ], 
        "name": "Annals of Hematology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "94"
      }
    ], 
    "keywords": [
      "hematopoietic stem cell transplantation", 
      "allo-BMT", 
      "allogeneic hematopoietic stem cell transplantation", 
      "stem cell transplantation", 
      "day 30", 
      "HG patients", 
      "cell transplantation", 
      "higher non-relapse mortality", 
      "non-relapse mortality", 
      "subsequent survival outcomes", 
      "independent prognostic factor", 
      "low IgG levels", 
      "common clinical practice", 
      "acute graft", 
      "acute GVHD", 
      "unrelated donors", 
      "relapse rate", 
      "related donors", 
      "prognostic factors", 
      "clinical features", 
      "IgG levels", 
      "survival outcomes", 
      "hematogones", 
      "grade II", 
      "clinical impact", 
      "better outcomes", 
      "bone marrow", 
      "patients", 
      "clinical practice", 
      "fungal infections", 
      "BMT", 
      "cell precursors", 
      "transplantation", 
      "outcomes", 
      "recent reports", 
      "useful indicator", 
      "donors", 
      "GVHD", 
      "chemotherapy", 
      "HLA", 
      "graft", 
      "marrow", 
      "mortality", 
      "infection", 
      "levels", 
      "report", 
      "factors", 
      "differences", 
      "rate", 
      "emergence", 
      "indicators", 
      "practice", 
      "impact", 
      "features", 
      "precursors", 
      "emergence of HGs", 
      "HG-negative (\u2212) patients"
    ], 
    "name": "Clinical impact of hematogones on outcomes of allogeneic hematopoietic stem cell transplantation", 
    "pagination": "2055-2060", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1045268198"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00277-015-2492-y"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26336968"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00277-015-2492-y", 
      "https://app.dimensions.ai/details/publication/pub.1045268198"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:37", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_669.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00277-015-2492-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-015-2492-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-015-2492-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-015-2492-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-015-2492-y'


 

This table displays all metadata directly associated to this object as RDF triples.

264 TRIPLES      22 PREDICATES      103 URIs      92 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00277-015-2492-y schema:about N013e9aab62324fc4ba422c5457c2b8ea
2 N1e836b2d04ed4aa88ebfc4a67dcc499b
3 N3059ffa4b8a34a2096936e97809ca19f
4 N4db141a4978e4f0f8f6103248ad9582e
5 N4faa6b5255894a89aea9b73145ebfa89
6 N531f272256744b6da582a338b9b76efd
7 N652abd469a1145f4a4a2c374862d7b73
8 N72186fc48ea54f8a80675a4edb0e5a89
9 N882c32cda386453f87cfd79884d534fc
10 N908ab785fa9a45adaaae727425c9d304
11 N93a41f8496104d1c8acd33aeda5edadc
12 Na01ec770093d4e99a9ad26fcd9cbbb13
13 Nae1ca4d75faf4ceba74c0b352dd2731b
14 Nb8900e75916943368a24c285d52931df
15 Nb8b470fd4d794f51b6eab203abcde533
16 Ncea75065d8a744c0a3acd6b81372b8a8
17 Ne3333f8bf00e462e8c341ad9ad887e13
18 anzsrc-for:11
19 anzsrc-for:1102
20 schema:author N5d6ebeec8d4544e7829e74bc80f478fc
21 schema:citation sg:pub.10.1038/bmt.2011.93
22 sg:pub.10.1038/bmt.2013.34
23 sg:pub.10.1038/sj.leu.2401279
24 schema:datePublished 2015-09-04
25 schema:datePublishedReg 2015-09-04
26 schema:description Increased levels of normal B cell precursors, termed hematogones (HGs), are observed in regenerating bone marrow after chemotherapy or hematopoietic stem cell transplantation (HSCT). Recent reports suggest that emergence of HGs is associated with better outcomes following allogeneic HSCT (allo-HSCT). We reviewed the emergence of HGs and the clinical features of 192 patients after allo-BMT. Patients undergoing allo-BMT from related donors were more likely to develop HGs at day 30 compared to unrelated donors. Furthermore, patients undergoing allo-BMT from HLA-mismatched donors were less likely to develop HGs at day 30. The emergence of HGs at day 30 was an independent prognostic factor among patients who underwent BMT. We found no difference in the relapse rate between HG-positive (+) and HG-negative (−) patients undergoing BMT. HG (−) patients had high non-relapse mortality, grade II to IV acute graft-versus-host-disease (GVHD), fungal infection, and lower IgG levels compared to HG (+) patients. The emergence of HGs at day 30 among patients undergoing BMT may be a very useful indicator of subsequent survival outcomes or acute GVHD in common clinical practice.
27 schema:genre article
28 schema:inLanguage en
29 schema:isAccessibleForFree false
30 schema:isPartOf N9f5e87e78fad4d05894cae82bfe6692f
31 Nb0030a5dca9c4fce955072d8ede89ed5
32 sg:journal.1358129
33 schema:keywords BMT
34 GVHD
35 HG patients
36 HG-negative (−) patients
37 HLA
38 IgG levels
39 acute GVHD
40 acute graft
41 allo-BMT
42 allogeneic hematopoietic stem cell transplantation
43 better outcomes
44 bone marrow
45 cell precursors
46 cell transplantation
47 chemotherapy
48 clinical features
49 clinical impact
50 clinical practice
51 common clinical practice
52 day 30
53 differences
54 donors
55 emergence
56 emergence of HGs
57 factors
58 features
59 fungal infections
60 grade II
61 graft
62 hematogones
63 hematopoietic stem cell transplantation
64 higher non-relapse mortality
65 impact
66 independent prognostic factor
67 indicators
68 infection
69 levels
70 low IgG levels
71 marrow
72 mortality
73 non-relapse mortality
74 outcomes
75 patients
76 practice
77 precursors
78 prognostic factors
79 rate
80 recent reports
81 relapse rate
82 related donors
83 report
84 stem cell transplantation
85 subsequent survival outcomes
86 survival outcomes
87 transplantation
88 unrelated donors
89 useful indicator
90 schema:name Clinical impact of hematogones on outcomes of allogeneic hematopoietic stem cell transplantation
91 schema:pagination 2055-2060
92 schema:productId N4ade15047bec42db881bf5e7e594de9a
93 N5f6e3614542c4fd0b0778b702a62984d
94 N6f3bc034c4ab4b96b5a7c63d29eb5777
95 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045268198
96 https://doi.org/10.1007/s00277-015-2492-y
97 schema:sdDatePublished 2022-01-01T18:37
98 schema:sdLicense https://scigraph.springernature.com/explorer/license/
99 schema:sdPublisher N1dcf07ed05c2446a9ef2ab1fcfb84397
100 schema:url https://doi.org/10.1007/s00277-015-2492-y
101 sgo:license sg:explorer/license/
102 sgo:sdDataset articles
103 rdf:type schema:ScholarlyArticle
104 N013e9aab62324fc4ba422c5457c2b8ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Lymphocyte Count
106 rdf:type schema:DefinedTerm
107 N0b9f740bb0aa4466a3a26169a0b4b34c rdf:first sg:person.0677710136.43
108 rdf:rest N86dd010b1c6241cc81e0176e43dda6b0
109 N1dcf07ed05c2446a9ef2ab1fcfb84397 schema:name Springer Nature - SN SciGraph project
110 rdf:type schema:Organization
111 N1e836b2d04ed4aa88ebfc4a67dcc499b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Histocompatibility Testing
113 rdf:type schema:DefinedTerm
114 N2ab6f7230b72407cb22c53e0f0eb2c6d rdf:first sg:person.0644344774.08
115 rdf:rest N6d4ab1142312423682056b49d9d8db87
116 N3059ffa4b8a34a2096936e97809ca19f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Adolescent
118 rdf:type schema:DefinedTerm
119 N402432c918914f4383cb237c6afa0212 rdf:first sg:person.01355201036.66
120 rdf:rest N0b9f740bb0aa4466a3a26169a0b4b34c
121 N4ade15047bec42db881bf5e7e594de9a schema:name dimensions_id
122 schema:value pub.1045268198
123 rdf:type schema:PropertyValue
124 N4db141a4978e4f0f8f6103248ad9582e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Hematologic Neoplasms
126 rdf:type schema:DefinedTerm
127 N4faa6b5255894a89aea9b73145ebfa89 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Bone Marrow
129 rdf:type schema:DefinedTerm
130 N531f272256744b6da582a338b9b76efd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Disease-Free Survival
132 rdf:type schema:DefinedTerm
133 N5d6ebeec8d4544e7829e74bc80f478fc rdf:first sg:person.01240752436.35
134 rdf:rest N2ab6f7230b72407cb22c53e0f0eb2c6d
135 N5f6e3614542c4fd0b0778b702a62984d schema:name doi
136 schema:value 10.1007/s00277-015-2492-y
137 rdf:type schema:PropertyValue
138 N652abd469a1145f4a4a2c374862d7b73 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Precursor Cells, B-Lymphoid
140 rdf:type schema:DefinedTerm
141 N6d4ab1142312423682056b49d9d8db87 rdf:first sg:person.01142075071.52
142 rdf:rest Nf4c30e73c169470695269eab102eb2d2
143 N6f3bc034c4ab4b96b5a7c63d29eb5777 schema:name pubmed_id
144 schema:value 26336968
145 rdf:type schema:PropertyValue
146 N72186fc48ea54f8a80675a4edb0e5a89 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Female
148 rdf:type schema:DefinedTerm
149 N86dd010b1c6241cc81e0176e43dda6b0 rdf:first sg:person.01243551065.00
150 rdf:rest N95726deae7024801bbba8035c94b65d4
151 N882c32cda386453f87cfd79884d534fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Allografts
153 rdf:type schema:DefinedTerm
154 N908ab785fa9a45adaaae727425c9d304 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Regeneration
156 rdf:type schema:DefinedTerm
157 N929901cf3d0c4054bcbf060ba6ce7421 rdf:first sg:person.012430503152.76
158 rdf:rest rdf:nil
159 N93a41f8496104d1c8acd33aeda5edadc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Humans
161 rdf:type schema:DefinedTerm
162 N95726deae7024801bbba8035c94b65d4 rdf:first sg:person.01143751601.01
163 rdf:rest N929901cf3d0c4054bcbf060ba6ce7421
164 N9f5e87e78fad4d05894cae82bfe6692f schema:volumeNumber 94
165 rdf:type schema:PublicationVolume
166 Na01ec770093d4e99a9ad26fcd9cbbb13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Middle Aged
168 rdf:type schema:DefinedTerm
169 Nae1ca4d75faf4ceba74c0b352dd2731b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Survival Rate
171 rdf:type schema:DefinedTerm
172 Nb0030a5dca9c4fce955072d8ede89ed5 schema:issueNumber 12
173 rdf:type schema:PublicationIssue
174 Nb8900e75916943368a24c285d52931df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Male
176 rdf:type schema:DefinedTerm
177 Nb8b470fd4d794f51b6eab203abcde533 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Aged
179 rdf:type schema:DefinedTerm
180 Nca67b3373a2a4ebfa84894fd47ce2978 rdf:first sg:person.01214267464.19
181 rdf:rest N402432c918914f4383cb237c6afa0212
182 Ncea75065d8a744c0a3acd6b81372b8a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Hematopoietic Stem Cell Transplantation
184 rdf:type schema:DefinedTerm
185 Ne3333f8bf00e462e8c341ad9ad887e13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Adult
187 rdf:type schema:DefinedTerm
188 Nf4c30e73c169470695269eab102eb2d2 rdf:first sg:person.0643633551.26
189 rdf:rest Nca67b3373a2a4ebfa84894fd47ce2978
190 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
191 schema:name Medical and Health Sciences
192 rdf:type schema:DefinedTerm
193 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
194 schema:name Cardiorespiratory Medicine and Haematology
195 rdf:type schema:DefinedTerm
196 sg:journal.1358129 schema:issn 0939-5555
197 1432-0584
198 schema:name Annals of Hematology
199 schema:publisher Springer Nature
200 rdf:type schema:Periodical
201 sg:person.01142075071.52 schema:affiliation grid-institutes:grid.415479.a
202 schema:familyName Hagino
203 schema:givenName Takeshi
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142075071.52
205 rdf:type schema:Person
206 sg:person.01143751601.01 schema:affiliation grid-institutes:grid.415479.a
207 schema:familyName Sakamaki
208 schema:givenName Hisashi
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143751601.01
210 rdf:type schema:Person
211 sg:person.01214267464.19 schema:affiliation grid-institutes:grid.415479.a
212 schema:familyName Najima
213 schema:givenName Yuho
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01214267464.19
215 rdf:type schema:Person
216 sg:person.01240752436.35 schema:affiliation grid-institutes:grid.415479.a
217 schema:familyName Doki
218 schema:givenName Noriko
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240752436.35
220 rdf:type schema:Person
221 sg:person.012430503152.76 schema:affiliation grid-institutes:grid.415479.a
222 schema:familyName Ohashi
223 schema:givenName Kazuteru
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012430503152.76
225 rdf:type schema:Person
226 sg:person.01243551065.00 schema:affiliation grid-institutes:grid.415479.a
227 schema:familyName Okuyama
228 schema:givenName Yoshiki
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243551065.00
230 rdf:type schema:Person
231 sg:person.01355201036.66 schema:affiliation grid-institutes:grid.415479.a
232 schema:familyName Kobayashi
233 schema:givenName Takeshi
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355201036.66
235 rdf:type schema:Person
236 sg:person.0643633551.26 schema:affiliation grid-institutes:grid.415479.a
237 schema:familyName Igarashi
238 schema:givenName Aiko
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643633551.26
240 rdf:type schema:Person
241 sg:person.0644344774.08 schema:affiliation grid-institutes:grid.415479.a
242 schema:familyName Haraguchi
243 schema:givenName Kyoko
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644344774.08
245 rdf:type schema:Person
246 sg:person.0677710136.43 schema:affiliation grid-institutes:grid.415479.a
247 schema:familyName Kakihana
248 schema:givenName Kazuhiko
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677710136.43
250 rdf:type schema:Person
251 sg:pub.10.1038/bmt.2011.93 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011498187
252 https://doi.org/10.1038/bmt.2011.93
253 rdf:type schema:CreativeWork
254 sg:pub.10.1038/bmt.2013.34 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001540761
255 https://doi.org/10.1038/bmt.2013.34
256 rdf:type schema:CreativeWork
257 sg:pub.10.1038/sj.leu.2401279 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018364937
258 https://doi.org/10.1038/sj.leu.2401279
259 rdf:type schema:CreativeWork
260 grid-institutes:grid.415479.a schema:alternateName Division of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
261 Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan
262 schema:name Division of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
263 Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, 113-8677, Tokyo, Japan
264 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...